Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Bexell

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Cell and Tissue Research|September 20, 2017
Patient-derived xenografts as preclinical neuroblastoma modelsNoémie Braekeveldt, Daniel Bexell
Cancer Treatment Reviews|July 17, 2012
Stem cell-based therapy for malignant gliomaDaniel Bexell, Andreas Svensson, Johan Bengzon
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 22, 2010
Toward brain tumor gene therapy using multipotent mesenchymal stromal cell vectorsDaniel Bexell, Stefan Scheding, Johan Bengzon
Pharmacology & Therapeutics|May 4, 2016
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancerCaroline Wigerup, Sven Påhlman, Daniel Bexell
Oncotarget|February 5, 2019
Multidimensional intratumour heterogeneity in neuroblastomaKristoffer von Stedingk, David Gisselsson, Daniel Bexell
International Journal of Cancer|March 18, 2009
CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomasDaniel Bexell, Salina Gunnarsson, Peter Siesjö, et al.
Journal of Neuroimmunology|November 17, 2009
Intratumoral IL-7 delivery by mesenchymal stromal cells potentiates IFNgamma-transduced tumor cell immunotherapy of experimental gliomaSalina Gunnarsson, Daniel Bexell, Andreas Svensson, et al.
Frontiers in Oncology|February 13, 2023
Patient-derived models: Advanced tools for precision medicine in neuroblastomaKristina Aaltonen, Katarzyna Radke, Aleksandra Adamska, et al.
Pediatric Blood & Cancer|July 22, 2014
Orthotopic Wilms tumor xenografts derived from cell lines reflect limited aspects of tumor morphology and clinical characteristicsLinda Holmquist Mengelbier, Daniel Bexell, Daniel Sehic, et al.
Stem Cell Research & Therapy|October 16, 2021
Label-free separation of neuroblastoma patient-derived xenograft (PDX) cells from hematopoietic progenitor cell products by acoustophoresisFranziska Olm, Lena Panse, Josefina H Dykes, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Cell and Tissue Research|September 20, 2017
Patient-derived xenografts as preclinical neuroblastoma modelsNoémie Braekeveldt, Daniel Bexell
Cancer Treatment Reviews|July 17, 2012
Stem cell-based therapy for malignant gliomaDaniel Bexell, Andreas Svensson, Johan Bengzon
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 22, 2010
Toward brain tumor gene therapy using multipotent mesenchymal stromal cell vectorsDaniel Bexell, Stefan Scheding, Johan Bengzon
Pharmacology & Therapeutics|May 4, 2016
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancerCaroline Wigerup, Sven Påhlman, Daniel Bexell
Oncotarget|February 5, 2019
Multidimensional intratumour heterogeneity in neuroblastomaKristoffer von Stedingk, David Gisselsson, Daniel Bexell
International Journal of Cancer|March 18, 2009
CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomasDaniel Bexell, Salina Gunnarsson, Peter Siesjö, et al.
Journal of Neuroimmunology|November 17, 2009
Intratumoral IL-7 delivery by mesenchymal stromal cells potentiates IFNgamma-transduced tumor cell immunotherapy of experimental gliomaSalina Gunnarsson, Daniel Bexell, Andreas Svensson, et al.
Frontiers in Oncology|February 13, 2023
Patient-derived models: Advanced tools for precision medicine in neuroblastomaKristina Aaltonen, Katarzyna Radke, Aleksandra Adamska, et al.
Pediatric Blood & Cancer|July 22, 2014
Orthotopic Wilms tumor xenografts derived from cell lines reflect limited aspects of tumor morphology and clinical characteristicsLinda Holmquist Mengelbier, Daniel Bexell, Daniel Sehic, et al.
Stem Cell Research & Therapy|October 16, 2021
Label-free separation of neuroblastoma patient-derived xenograft (PDX) cells from hematopoietic progenitor cell products by acoustophoresisFranziska Olm, Lena Panse, Josefina H Dykes, et al.
Pageof 5